Even though NTRK rearrangement is threefold less frequent than RET mutations, a prevalence of TRK fusions has been reported between 5–25% in thyroid cancer and may be seen in DTC, PDTC and ATC. This evidence concerns the gene NTRK1 and thyroid cancer.